Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients

NCT00574652 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cryoglobulinemia Vasculitis

Interventions

DRUG: Proleukin

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis